- Home
- NCNA vs NUWE Comparison
NCNA vs NUWE Comparison
Compare NCNA & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- NUWE
- Stock Information
- Founded
- NCNA 1997
- NUWE 1999
- Country
- NCNA United Kingdom
- NUWE United States
- Employees
- NCNA N/A
- NUWE N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NCNA Health Care
- NUWE Health Care
- Exchange
- NCNA Nasdaq
- NUWE Nasdaq
- Market Cap
- NCNA 4.5M
- NUWE 3.9M
- IPO Year
- NCNA 2017
- NUWE N/A
- Fundamental
- Price
- NCNA $0.65
- NUWE $0.93
- Analyst Decision
- NCNA Buy
- NUWE Strong Buy
- Analyst Count
- NCNA 2
- NUWE 1
- Target Price
- NCNA $25.00
- NUWE $17.00
- AVG Volume (30 Days)
- NCNA 140.2K
- NUWE 61.5K
- Earning Date
- NCNA 05-15-2025
- NUWE 05-06-2025
- Dividend Yield
- NCNA N/A
- NUWE N/A
- EPS Growth
- NCNA N/A
- NUWE N/A
- EPS
- NCNA N/A
- NUWE N/A
- Revenue
- NCNA N/A
- NUWE $8,740,000.00
- Revenue This Year
- NCNA N/A
- NUWE $22.96
- Revenue Next Year
- NCNA N/A
- NUWE $29.97
- P/E Ratio
- NCNA N/A
- NUWE N/A
- Revenue Growth
- NCNA N/A
- NUWE N/A
- 52 Week Low
- NCNA $0.69
- NUWE $0.75
- 52 Week High
- NCNA $10.79
- NUWE $14.00
- Technical
- Relative Strength Index (RSI)
- NCNA 39.85
- NUWE 47.12
- Support Level
- NCNA $0.71
- NUWE $0.86
- Resistance Level
- NCNA $0.89
- NUWE $0.95
- Average True Range (ATR)
- NCNA 0.09
- NUWE 0.08
- MACD
- NCNA -0.00
- NUWE 0.01
- Stochastic Oscillator
- NCNA 12.68
- NUWE 76.71
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.